Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 1
JACOB: Joint Administration of cDNA for TP53, checkpOint Inhibition and Boost/Hypofractionated Radiation. A Phase 0/1 Study in Children With Recurrent, Progressive or Refractory CNS Malignancies.
This clinical trial is studying a drug called SGT-53 along with radiation and another drug called Nivolumab. It's for children with brain tumors that have come…
CNS MalignanciesMedulloblastoma RecurrentATRT Recurrent+4 more
Children's National Research InstituteNCT07017816
Phase 2
A Phase II Study of Metronomic and Targeted Anti-angiogenesis Therapy for Children With Recurrent/Progressive Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors
Patients with with recurrent or progressive medulloblastoma, ependymoma, atypical teratoid rhabdoid tumor (ATRT), and CNS tumors of various histologies have a …
Medulloblastoma RecurrentEpendymoma RecurrentATRT Recurrent+1 more
Medical University of ViennaNCT01356290